Skip to main content
INM logo

InMed Pharmaceuticals Inc. (INM) Stock Analysis

DELISTED

What happened to InMed Pharmaceuticals Inc. (INM) stock?

InMed Pharmaceuticals Inc. (INM) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
MCap: $8.55M| P/E Ratio: 14.58| Vol: 27.2K| 52-wk range: $5.75 – $23.30

P/E 14.58 means the share price is 14.58 times one year of earnings per share. Market cap $8.55M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

InMed Pharmaceuticals Inc. (INM). InMed Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on researching and developing cannabinoid-based therapies for various diseases, including epidermolysis bullosa, glaucoma, and pain.

Last analyzed: Jun 15, 2026
InMed Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on researching and developing cannabinoid-based therapies for various diseases, including epidermolysis bullosa, glaucoma, and pain. The company is advancing its lead product, INM-755, through clinical trials while also developing a proprietary biosynthesis manufacturing approach.

InMed Pharmaceuticals Inc. (INM) Healthcare & Pipeline Overview

Model self-rating on this text: 68% (not a measure of the evidence) Updated: Jun 15, 2026

More about this archive record

Can I still buy INM shares?

No. INM stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for INM elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before INM stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to InMed Pharmaceuticals Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.